HL7 Electronic Health Record System Functional Model, Release 2.1.1
2.1.1-ballot - Normative Ballot International flag

This page is part of the HL7 Electronic Health Record System Functional Model, Release 2.1.1 (v2.1.1-ballot: Normative 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions

Requirements: CP.4.2.1 Medication Interaction and Allergy Checking (Function)

Page standards status: Informative
Statement N:

Provide alerts for potential medication interactions and medication allergy reactions.

 Description I:

Check and provide alerts at the time of medication order based upon coded, active and non-active medications for possible interactions, allergies, sensitivities, intolerances, and other adverse reactions.

 Actors:
ehr Criteria N:
CP.4.2.1#01 SHALL

The system SHALL conform to function CPS.4.2.1 (Support for Medication Interaction and Allergy Checking) to determine allergic reactions, drug-drug interactions, and other potential adverse reactions, and render alerts or notifications when new medications are ordered.
CP.4.2.1#02 SHALL

The system SHALL conform to function CP.1.2 (Manage Allergy, Intolerance and Adverse Reaction List) to provide the ability to manage interaction and allergy checking and render alerts and notifications when new medications are ordered.
CP.4.2.1#03 MAY

The system MAY provide the ability to render an alert, at the time a new medication is prescribed/ordered, that drug interaction, allergy, and formulary checking will not be performed against uncoded or free text medication(s).
CP.4.2.1#04 dependent MAY

The system MAY provide the ability to render a notification, at the time a new uncoded medication is prescribed/ordered, that drug interaction, allergy, and formulary checking will not be performed, according to scope of practice, organizational policy, and/or jurisdictional law.
CP.4.2.1#05 dependent SHALL

The system SHALL provide the ability to render and tag as inactive recently inactivated medications for inclusion in current medication screening according to scope of practice, organizational policy, and/or jurisdictional law.